Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Burrows

Showing results (131-140 of 152) with videos related to

Pageof 16
Sort By:
Journal of Neurochemistry|August 11, 2006
Antigen-specific therapy promotes repair of myelin and axonal damage in established EAEChunhe Wang, Bruce G Gold, Laurie J Kaler, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 16, 2007
A promising therapeutic approach for multiple sclerosis: recombinant T-cell receptor ligands modulate experimental autoimmune encephalomyelitis by reducing interleukin-17 production and inhibiting migration of encephalitogenic cells into the CNSSushmita Sinha, Sandhya Subramanian, Thomas M Proctor, et al.
Metabolic Brain Disease|April 8, 2011
Therapy with recombinant T-cell receptor ligand reduces infarct size and infiltrating inflammatory cells in brain after middle cerebral artery occlusion in miceSuzan Dziennis, Sarah Mader, Kozaburo Akiyoshi, et al.
European Journal of Immunology|April 7, 2011
TCR-like antibodies distinguish conformational and functional differences in two- versus four-domain auto reactive MHC class II-peptide complexesRony Dahan, Moran Tabul, Yuan K Chou, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|October 1, 2009
Recombinant TCR ligand reverses clinical signs and CNS damage of EAE induced by recombinant human MOGSushmita Sinha, Sandhya Subramanian, Ashley Emerson-Webber, et al.
Journal of Neuroimmunology|June 16, 2010
Binding of recombinant T cell receptor ligands (RTL) to antigen presenting cells prevents upregulation of CD11b and inhibits T cell activation and transfer of experimental autoimmune encephalomyelitisSushmita Sinha, Lisa Miller, Sandhya Subramanian, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 2014
HLA-DRα1 constructs block CD74 expression and MIF effects in experimental autoimmune encephalomyelitisRoberto Meza-Romero, Gil Benedek, Xiaolin Yu, et al.
Journal of Neuroinflammation|November 10, 2010
Characterization of human platelet binding of recombinant T cell receptor ligandAsako Itakura, Joseph E Aslan, Sushmita Sinha, et al.
Stem Cells Translational Medicine|August 29, 2013
Dissection of the human multipotent adult progenitor cell secretome by proteomic analysisGregory G Burrows, Wouter Van't Hof, Laura F Newell, et al.
Marine Environmental Research|August 29, 2006
Use of chemical tracers in assessing the diet and foraging regions of eastern North Pacific killer whalesMargaret M Krahn, David P Herman, Craig O Matkin, et al.
Pageof 16

Showing results (131-140 of 152) with videos related to

Sort By:
Pageof 16
Journal of Neurochemistry|August 11, 2006
Antigen-specific therapy promotes repair of myelin and axonal damage in established EAEChunhe Wang, Bruce G Gold, Laurie J Kaler, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 16, 2007
A promising therapeutic approach for multiple sclerosis: recombinant T-cell receptor ligands modulate experimental autoimmune encephalomyelitis by reducing interleukin-17 production and inhibiting migration of encephalitogenic cells into the CNSSushmita Sinha, Sandhya Subramanian, Thomas M Proctor, et al.
Metabolic Brain Disease|April 8, 2011
Therapy with recombinant T-cell receptor ligand reduces infarct size and infiltrating inflammatory cells in brain after middle cerebral artery occlusion in miceSuzan Dziennis, Sarah Mader, Kozaburo Akiyoshi, et al.
European Journal of Immunology|April 7, 2011
TCR-like antibodies distinguish conformational and functional differences in two- versus four-domain auto reactive MHC class II-peptide complexesRony Dahan, Moran Tabul, Yuan K Chou, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|October 1, 2009
Recombinant TCR ligand reverses clinical signs and CNS damage of EAE induced by recombinant human MOGSushmita Sinha, Sandhya Subramanian, Ashley Emerson-Webber, et al.
Journal of Neuroimmunology|June 16, 2010
Binding of recombinant T cell receptor ligands (RTL) to antigen presenting cells prevents upregulation of CD11b and inhibits T cell activation and transfer of experimental autoimmune encephalomyelitisSushmita Sinha, Lisa Miller, Sandhya Subramanian, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 2014
HLA-DRα1 constructs block CD74 expression and MIF effects in experimental autoimmune encephalomyelitisRoberto Meza-Romero, Gil Benedek, Xiaolin Yu, et al.
Journal of Neuroinflammation|November 10, 2010
Characterization of human platelet binding of recombinant T cell receptor ligandAsako Itakura, Joseph E Aslan, Sushmita Sinha, et al.
Stem Cells Translational Medicine|August 29, 2013
Dissection of the human multipotent adult progenitor cell secretome by proteomic analysisGregory G Burrows, Wouter Van't Hof, Laura F Newell, et al.
Marine Environmental Research|August 29, 2006
Use of chemical tracers in assessing the diet and foraging regions of eastern North Pacific killer whalesMargaret M Krahn, David P Herman, Craig O Matkin, et al.
Pageof 16